
ROCHESTER, Minn. — May 14, 2012. Brad Anderson, retired CEO of Best Buy, and Thomas Zeltner, M.D., former Swiss Secretary of State for Health, will keynote the Mayo Clinic Quality and Systems Engineering Conference on May 14–16, at Mayo Civic Center, Rochester, Minn.
Anderson, who started at Best Buy as a commissioned salesperson and rose to the company's highest position, will discuss how staff at all levels can lead. Dr. Zeltner, an expert in international health reform and patient safety, will address quality improvement and health equity.
Participants choose from four tracks — systems engineering, quality, hot topics and the needs of the patient — to customize their conference experience. Sessions include:
This year's conference offers participants an opportunity to hear directly from patients about their experiences with the health care delivery system. More than 20 patients will share both positive and negative stories about seeking care for themselves or a family member. For example, Jill Keach will share the story of her fifth-grade daughter's diagnosis of leukemia and subsequent treatments at Mayo Clinic. Attendees will interact with Keach and other patients via roundtable discussion, first identifying key lessons from the patient's story and then brainstorming potential solutions to any unresolved problems.
Original research also will be presented during oral abstract and poster sessions. Featured research includes:
Please contact Shelly Plutowski at 507-248-5005 or newsbureau@mayo.edu if you are interested in attending portions of the conference.
###
About Mayo Clinic:
Recognizing 150 years of serving humanity in 2014, Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. For more information, visit 150years.mayoclinic.org, www.mayoclinic.org and newsnetwork.mayoclinic.org.
Media Contact: Shelly Plutowski, 507-284-5005 (days), newsbureau@mayo.edu
ROCHESTER, Minn. — Researchers from Mayo Clinic Comprehensive Cancer Center and Mayo Clinic Center for Individualized Medicine have discovered new genetic markers to identify Lynch ...
ROCHESTER, Minn. — Survival outcomes using chimeric antigen receptor-T cell therapy (CAR-T cell therapy) continue to be impressive for patients with some blood cancers. “Five years ...
ROCHESTER, Minn. — In a randomized trial, published in The Lancet Oncology, Mayo Clinic Comprehensive Cancer Center researchers uncover evidence supporting a shorter treatment time ...